DYAI Company Profile and Key Details

Q: Who are the executives of DYAI?

Ms. Ping Wang Rawson CPA, M.B.A.Chief Financial OfficerDr. Ronen Tchelet Ph.D.Vice President of Research & Bus. Devel.Ms. Ana Gómez RodriguezSec. of the BoardMr. Mark A. EmalfarbFounder, Chief Executive Officer, Pres & DirectorMr. Joseph P. HazeltonChief Bus. OfficerMs. Ping Wang Rawson C.P.A., M.B.A.Chief Financial Officer

NASDAQ : DYAI

Dyadic International

$0.80

-0.0073-0.90%

At Close 4:00 PM

68.49

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Dyadic International, Inc. (DYAI) stock declined over -0.90%, trading at $0.80 on NASDAQ, down from the previous close of $0.81. The stock opened at $0.82, fluctuating between $0.75 and $0.82 in the recent session.

Stock Snapshot

0.8094

Prev. Close

29.03M

Market Cap

0.7502

Day Low

-3.65

P/E Ratio

-0.22

EPS (TTM)

-0.23

Cash Flow per Share

0.82

Open

36.19M

Number of Shares

0.8198

Day High

74.51%

Free Float in %

0.2

Book Value

125.81K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 17, 2026	0.84	0.85	0.75	0.80	125.91K
Mar 16, 2026	0.79	0.83	0.77	0.81	141.9K
Mar 13, 2026	0.78	0.80	0.76	0.76	36.07K
Mar 12, 2026	0.80	0.81	0.73	0.76	64.06K
Mar 11, 2026	0.83	0.83	0.79	0.80	22.68K
Mar 10, 2026	0.83	0.83	0.78	0.83	70.45K
Mar 09, 2026	0.77	0.83	0.75	0.80	305.71K
Mar 06, 2026	0.85	0.85	0.75	0.77	44.6K
Mar 03, 2026	0.77	0.79	0.77	0.79	12.71K
Mar 02, 2026	0.79	0.80	0.74	0.77	103.15K
Feb 27, 2026	0.78	0.79	0.76	0.78	73.15K
Feb 26, 2026	0.83	0.83	0.78	0.78	41.66K
Feb 25, 2026	0.80	0.84	0.80	0.84	13.48K
Feb 24, 2026	0.80	0.82	0.79	0.82	52.96K
Feb 23, 2026	0.79	0.81	0.75	0.80	19.06K
Feb 20, 2026	0.81	0.82	0.80	0.80	4.86K
Feb 19, 2026	0.81	0.83	0.79	0.80	21.89K
Feb 18, 2026	0.80	0.83	0.79	0.81	131.09K
Feb 17, 2026	0.85	0.85	0.79	0.81	28.4K
Feb 13, 2026	0.83	0.90	0.83	0.83	92.17K

Contact Details

Jupiter, FL 33477-5094

United States

https://www.dyadic.com 561 743 8333

About Company

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Stock Peers

REGN

2.14+0.28%

Regeneron Pharmaceuticals, Inc.$759.05 ARGX

2.73+0.39%

argenx SE$706.03 UTHR

5.72001+1.07%

United Therapeutics Corporation$540.02 VRTX

-3.61-0.77%

Vertex Pharmaceuticals Incorporated$462.49 MDGL

2.35+0.53%

Madrigal Pharmaceuticals, Inc.$443.18 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.51+0.47%

Alnylam Pharmaceuticals, Inc.$320.42 PRAX

-1.62-0.53%

Praxis Precision Medicines, Inc.$303.38 KRYS

6.17+2.47%

Krystal Biotech, Inc.$256.33 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Company Overview

Dyadic International, Inc. (NASDAQ:DYAI) closed at $0.80 USD, losing -$0.01 (-0.90%) from the previous close of $0.81. The stock is currently mid-range between its 52-week high and low $0.71 and $1.47. With a market capitalization of about $29.03 million, Dyadic International, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.29). Key stats such as the average daily volume over the past year has been around 64.30 thousand shares, trading with heavier-than-usual volume. Headquartered in Jupiter, FL, Dyadic International, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Mark A. Emalfarb, the company employs approximately 6 people and listed since January 16, 2008. Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 -6.02%, SMA50 -11.56%, SMA200 -19.55%). The stock’s 14-day RSI is 37.44 (weak momentum), while the ATR of 0.05 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -49.66% below its high and over 9.73% above its low. Average 10-day trading volume of 109.54 thousand shares is significantly above the 3-month average of 60.22 thousand, indicating heightened recent market interest.

Valuation Metrics

Dyadic International, Inc. trades at a P/E ratio of -3.85, slightly below the S&P 500 average, with a price-to-sales ratio of 11.29 and a price-to-book ratio of 10.85 reflecting a rich premium to book value. The P/FCF stands at -6.41, also below market averages. Compared to sector medians, Dyadic International, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

Dyadic International, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.21. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Dyadic International, Inc. generated EPS of -$0.24 over the past year. Five-year average earnings growth is 8.43%. Wall Street analysts project EPS growth of 29.53% annually over the next five years. The latest quarter delivered EPS of -$0.06. The next quarter is forecast at -$0.04. Next year's EPS is expected at -$10.87. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $3.00 to $3.00. The high target offers 275.0% upside. The low target suggests 275.0% downside. The mean target is $3.00. This offers 275.0% upside. Dyadic International, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 12, 2025, missed forecasts by 43.15%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 14.29% in March 28, 2024.

Shareholding & Insider Activity

Dyadic International, Inc. has 36.19 million shares outstanding. The public float is 26.91 million shares, elevated short interest at 0.42% of float. This equals 116.62 thousand shares. The short ratio is 0.87 days. Institutional investors hold 18.55% of the float. Insiders own 25.17%. Francisco Trust under agreement dated February 28, 1996 holds 3.55 million shares, KITT BARRY M has 1.96 million shares and WARNER STEPHEN J has 274.80 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Dyadic International generated $2.90M in revenue, or $0.10 per share. Gross margin was 31.84%, operating margin -282.58%, and net profit margin -234.42%. Returns are negative, with ROA at -82.68% and ROE at -115.60%.
On valuation metrics, Dyadic International trades at a P/E of -3.85, P/S of 11.29 and P/B of 10.85. The current ratio is 2.85 and quick ratio is 2.85. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -37.61 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 1.94, supported by a cash flow-to-debt ratio of -0.91.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Dyadic International posted revenue of $2.90M, down slightly from $2.93M in the prior quarter. Gross profit was $922.96K (margin 31.84%). Operating income was - $8.19M (margin -282.6%). Net income was- $6.80M (EPS - $0.24).
The company ended the quarter with $7.26M in cash and short-term investments, a total debt of $136.93K, and net debt of - $6.38M. Total assets were $8.22M, with equity of $5.88M. Financials further reflected weakness, with operating cash flow of - $6.73M, free cash flow of - $6.73M, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that Dyadic International, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.51%, with price expected at $0.79 by March 31, 2026, within a range of $0.77 to $0.81 3-Month Outlook: Projected fall of -65.09%, reaching $0.28 by June 15, 2026, with a range of $0.21 to $0.32. 1-Year Outlook: Projected gain of 932.29%, with price at $8.28 by March 17, 2027, within a range of $4.18 to $11.98.

Key Takeaways

Dyadic International, Inc. (NASDAQ:DYAI) shares are flat -5.8% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Dyadic International, Inc. trading at a premium to the broader market with a P/E of -3.85. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $5.60, suggesting 598.17% upside. Our AI forecast model points to short-term weakness (-1.51% over two weeks), a medium-term fall (-65.09% over three months), and a longer-term gain (932.29% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Dyadic International, Inc. (DYAI) stock price?

Dyadic International, Inc. (NASDAQ: DYAI) stock price is $0.80 in the last trading session. During the trading session, DYAI stock reached the peak price of $0.82 while $0.75 was the lowest point it dropped to. The percentage change in DYAI stock occurred in the recent session was -0.9% while the dollar amount for the price change in DYAI stock was - $0.01.

DYAI's industry and sector of operation?

The NASDAQ listed DYAI is part of Biotechnology industry that operates in the broader Healthcare sector. Dyadic International, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of DYAI?

Ms. Ping Wang Rawson CPA, M.B.A.
Chief Financial Officer
Dr. Ronen Tchelet Ph.D.
Vice President of Research & Bus. Devel.
Ms. Ana Gómez Rodriguez
Sec. of the Board
Mr. Mark A. Emalfarb
Founder, Chief Executive Officer, Pres & Director
Mr. Joseph P. Hazelton
Chief Bus. Officer
Ms. Ping Wang Rawson C.P.A., M.B.A.
Chief Financial Officer

How DYAI did perform over past 52-week?

DYAI's closing price is 12.97% higher than its 52-week low of $0.71 where as its distance from 52-week high of $1.47 is -45.8%.

How many employees does DYAI have?

Number of DYAI employees currently stands at 6.

Link for DYAI official website?

Official Website of DYAI is: https://www.dyadic.com

How do I contact DYAI?

DYAI could be contacted at phone 561 743 8333 and can also be accessed through its website. DYAI operates from 140 Intracoastal Pointe Drive, Jupiter, FL 33477-5094, United States.

How many shares of DYAI are traded daily?

DYAI stock volume for the day was 125.81K shares. The average number of DYAI shares traded daily for last 3 months was 64.3K.

What is the market cap of DYAI currently?

The market value of DYAI currently stands at $29.03M with its latest stock price at $0.80 and 36.19M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	6
Beta	1.29
Sales or Revenue	$2.90M
5Y Sales Change%	1.15%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

DYAI Company Profile and Key Details

Dyadic International

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook